These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25222480)

  • 1. Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding protein.
    van Dongen MA; Rattan R; Silpe J; Dougherty C; Michmerhuizen NL; Van Winkle M; Huang B; Choi SK; Sinniah K; Orr BG; Banaszak Holl MM
    Mol Pharm; 2014 Nov; 11(11):4049-58. PubMed ID: 25222480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles.
    Silpe JE; Sumit M; Thomas TP; Huang B; Kotlyar A; van Dongen MA; Banaszak Holl MM; Orr BG; Choi SK
    ACS Chem Biol; 2013 Sep; 8(9):2063-71. PubMed ID: 23855478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
    Qi R; Majoros I; Misra AC; Koch AE; Campbell P; Marotte H; Bergin IL; Cao Z; Goonewardena S; Morry J; Zhang S; Beer M; Makidon P; Kotlyar A; Thomas TP; Baker JR
    J Biomed Nanotechnol; 2015 Aug; 11(8):1431-41. PubMed ID: 26295143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Folic Acid and Poly(amidoamine) Dendrimer Interactions with Folate Binding Protein: A Force-Pulling Study.
    Leroueil PR; DiMaggio S; Leistra AN; Blanchette CD; Orme C; Sinniah K; Orr BG; Banaszak Holl MM
    J Phys Chem B; 2015 Sep; 119(35):11506-12. PubMed ID: 26256755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent.
    Zhang Y; Thomas TP; Lee KH; Li M; Zong H; Desai AM; Kotlyar A; Huang B; Holl MM; Baker JR
    Bioorg Med Chem; 2011 Apr; 19(8):2557-64. PubMed ID: 21459000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-Triggered Exosite Binding: Synergistic Dendrimer/Folic Acid Action for Achieving Specific, Tight-Binding to Folate Binding Protein.
    Chen J; van Dongen MA; Merzel RL; Dougherty CA; Orr BG; Kanduluru AK; Low PS; Marsh EN; Banaszak Holl MM
    Biomacromolecules; 2016 Mar; 17(3):922-7. PubMed ID: 26815158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio.
    Zong H; Thomas TP; Lee KH; Desai AM; Li MH; Kotlyar A; Zhang Y; Leroueil PR; Gam JJ; Banaszak Holl MM; Baker JR
    Biomacromolecules; 2012 Apr; 13(4):982-91. PubMed ID: 22360561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
    Thomas TP; Huang B; Choi SK; Silpe JE; Kotlyar A; Desai AM; Zong H; Gam J; Joice M; Baker JR
    Mol Pharm; 2012 Sep; 9(9):2669-2676. PubMed ID: 22827500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis.
    Shi X; Majoros IJ; Patri AK; Bi X; Islam MT; Desai A; Ganser TR; Baker JR
    Analyst; 2006 Mar; 131(3):374-81. PubMed ID: 16496045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.
    Zhang Y; Thomas TP; Desai A; Zong H; Leroueil PR; Majoros IJ; Baker JR
    Bioconjug Chem; 2010 Mar; 21(3):489-95. PubMed ID: 20128612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
    Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
    J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
    Myc A; Douce TB; Ahuja N; Kotlyar A; Kukowska-Latallo J; Thomas TP; Baker JR
    Anticancer Drugs; 2008 Feb; 19(2):143-9. PubMed ID: 18176110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport.
    Hong S; Bielinska AU; Mecke A; Keszler B; Beals JL; Shi X; Balogh L; Orr BG; Baker JR; Banaszak Holl MM
    Bioconjug Chem; 2004; 15(4):774-82. PubMed ID: 15264864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic.
    Huang B; Otis J; Joice M; Kotlyar A; Thomas TP
    Biomacromolecules; 2014 Mar; 15(3):915-23. PubMed ID: 24392665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein.
    Shi X; Bi X; Ganser TR; Hong S; Myc LA; Desai A; Holl MM; Baker JR
    Analyst; 2006 Jul; 131(7):842-8. PubMed ID: 16802031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates.
    Wu G; Barth RF; Yang W; Kawabata S; Zhang L; Green-Church K
    Mol Cancer Ther; 2006 Jan; 5(1):52-9. PubMed ID: 16432162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of dendrimer-methotrexate conjugates on methotrexate-sensitive and -resistant cell lines.
    Gurdag S; Khandare J; Stapels S; Matherly LH; Kannan RM
    Bioconjug Chem; 2006; 17(2):275-83. PubMed ID: 16536456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioanalytical method development for a generation 5 polyamidoamine folic acid methotrexate conjugated nanoparticle.
    van Haandel L; Stobaugh JF
    Anal Bioanal Chem; 2010 Jul; 397(5):1841-52. PubMed ID: 20431871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells.
    Medina SH; Chevliakov MV; Tiruchinapally G; Durmaz YY; Kuruvilla SP; Elsayed ME
    Biomaterials; 2013 Jun; 34(19):4655-66. PubMed ID: 23523429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.
    Majoros IJ; Thomas TP; Mehta CB; Baker JR
    J Med Chem; 2005 Sep; 48(19):5892-9. PubMed ID: 16161993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.